⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 3, 2024Open Access

Supplementary File S4 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Kanve N. Suvilesh Yariswamy Manjunath Yulia I. Nussbaum Mohamed Gadelkarim Murugesan Raju Akhil Srivastava Guangfu Li Wesley C. Warren Chi‐Ren Shyu Feng Gao Matthew A. Ciorba Jonathan B. Mitchem Satyanarayana Rachagani Jussuf T. Kaifi

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary File S4. Differentially expressed genes between resistant versus sensitive patient tumors (categorized based on PDTOs therapy outcome).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Suvilesh et al. (2024) studied this question.

synapsesocial.com/papers/68e598d9b6db64358753320d https://doi.org/10.1158/1078-0432.26926636

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary File S4 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
2Supplementary File S3 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
3Supplementary File S3 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
4Supplementary File S1 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
5Supplementary File S1 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024

Supplementary File S2 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
Supplementary File S2 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024
Supplementary Figure S8 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids2024